ULMS

Clinical trials for ULMS explained in plain language.

Never miss a new study

Get alerted when new ULMS trials appear

Sign up with your email to follow new studies for ULMS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

Could a pill that blocks estrogen help fight rare uterine cancers?

Disease control Recruiting now

This phase 2 trial is testing elacestrant, a pill that breaks down estrogen receptors, in 30 people with advanced uterine sarcomas that are fueled by estrogen. The goal is to see if the drug can shrink tumors or slow their growth. Participants must have tumors that strongly expre…

Matched conditions: ULMS

Phase: PHASE2 • Sponsor: Dana-Farber Cancer Institute • Aim: Disease control

Last updated Jun 27, 2026 12:37 UTC

ULMS

Get alerted when new ULMS trials appear

Could a pill that blocks estrogen help fight rare uterine cancers?